Vasodilators and Ventricular Septal Defect: Comparison of Prazosin, Minoxidil, and Hydralazine in a Chronic Lamb Model

Pediatric Research, Sep 1984

Summary: The volume overloading of the left ventricle which results from left to right (L-R) shunting through a ventricular septal defect (VSD) may be reduced by pharmacologic agents which lower systemic vascular resistance (Rs) in excess of pulmonary arteriolar vascular resistance (Rpa). To study agents capable of decreasing the L-R shunt through systemic vasodilatation, we created a chronic lamb model with VSD and administered three vasodilators, prazosin (0.05 mg/kg), hydralazine (0.75 mg/kg), and minoxidil (0.25 mg/kg). Prazosin increased the Rpa while lowering Rs, resulting in an increase in Rpa/Rs by 43% {p ≤ 0.005). Prazosin decreased the pulmonary flow (Qp) slightly, decreased L-R shunt by 16%, reduced the pulmonary to systemic flow ratio (Qp/Qs) by 22% (p ≤ 0.005), and lowered the left atrial mean pressure (LA) by 16% (p ≤ 0.005) with no effect on heart rate. Hydralazine lowered the Rpa and Rs equally and thus did not change the Rpa/Rs or the volume of L-R shunt (7.6 versus 8.1 liters/min/m2). No change in LA was seen with hydralazine but heart rate increased from 162 to 200/min (p ≤ 0.01). Minoxidil did not change the L-R shunt (6.9 versus 6.8 liters/min/m2) and, in general, produced effects intermediate between prazosin and hydralazine. The data support a selective systemic vasodilation with prazosin, a property not shared by either minoxidil or hydralazine, which results in a reduction of shunting and left ventricular volume overloading in lambs with VSD. Furthermore, since prazosin did not decrease the pulmonary resistance, the data indicate that the elevation in pulmonary resistance in lambs with VSD is not mediated by the α1-adrenergic receptor.

Article PDF cannot be displayed. You can download it here:

https://www.nature.com/articles/pr19842172.pdf

Vasodilators and Ventricular Septal Defect: Comparison of Prazosin, Minoxidil, and Hydralazine in a Chronic Lamb Model

859 PREGNANT RABBIT METABOLISM pregnancy. Biochem J 156:357 18. Kalkhoff RK, Hissebah AM, Hak-Joong K 1978 Carbohydrate and lipid metabolism during normal pregnancy: relationship to gestational hormone action. Sem Perinatol2:291 19. Kewran A, Rieutort M, Guillaume M 1976 A simultaneous radioimmunoassay for growth hormone and insulin in the plasma of rats and rabbits. Diabetes Metab 2:67 20. Knopp RH, Saudek CD, Arky RA, O'Sullivan JB 1973 Two phases of adipose tissue metabolism in pregnancy: maternal adaptation for fetal growth. Endocrinology 92:984 21. Lebas F 1975 Etude chez la lapine de I'influence du niveau d'alimentation durant la gestation. Ann Zootech. 24:267 22. Leturque A, Ferre P, Satabin P, Kervran A, Girard J 1980 In vivo insulin resistance during pregnancy in the rat. Diabetologia 19:521 23. Leturque A, Gilbert M, Girard J 1981 Glucose turnover during pregnancy in anesthetized post-absorptive rats. Biochem J 196:633 24. Lopez-Quijada C, Gomez Acebo J, Candela JLR 1967 Decrease in the insulin of rabbit pancreas in late pregnancy. Diabetologia 3:435 25. Maurer RR, Hunt WL, Foote RH 1968 Repeated superovulation following administration of exogenous gonadotrophins in Dutch-belted rabbits. J Reprod Fert 15:93 26. McDonald-Gibson RG, Young M, Hytten FE 1975 Changes in plasma esterified fatty acids and serum glycerol in pregnancy. Br J Obstet Gynecol82:460 27. Metzger BE, Hare JW, Freinkel N 1971 Carbohydrate metabolism in pregnancy. IX. Plasma levels of gluconeogenic fuels during fasting in the rat. J Clin Endocrinol Metab 33:869 28. Metzger BE, Unger RH, Freinkel N 1977 Carbohydrate metabolism in pregnancy. XIV. Relationships between circulating glucagon, insulin, glucose and amino acids in response to a "mixed meal" in late pregnancy. Metabolism 26: 151 29. Pemon B, Lunell NO 1975 Metabolic control in diabetic pregnancy. Am J Obstet Gynecol 122:737 30. Phelps RL, Metzger BE, Freinkel N 1981 Carbohydrate metabolism in pregnancy. XVII. Diurnal profiles of plasma glucose, insulin, free-fatty acids, triglycerides, cholesterol and individual amino acids in late normal pregnancy. Am J Obstet Gynecol 140:730 31. Pitkin RM 1977 Obstetrics and gynecology. In: Schneider HA, Anderson CE, Coursin DB (eds) Nutritional Support of Medical Practice. Harper and Row, New York, pp 407-42 1 32. Saudek CD, Finkowski M, Knopp RH 1975 Plasma glucagon and insulin in rat pregnancy. Roles in glucose homeostasis. J Clin Invest 55:180 33. Scow RO, Chernick SS, Brinley MS 1964 Hyperlipemia and ketosis in the pregnant rat. Am J Physiol206:796 34. Silverstone FA, Solomon E, Rubricius J 1961 The rapid intravenous glucose tolerance test in pregnancy. J Clin Invest 40:2180 35. Sparks JW, Hay WW Jr, Meschia G, Battaglia FC 1982 Lactate production and utilization rates in the lamb fetus in vivo. J Clin Invest 70: 179 36. Sparks JW, Johnson R, Block S, Hay WW Jr, Meyers S, Mexhia G, Battaglia FC 1982 Comparative physiology of the pregnant chronically catheterized sheep, guinea pig and rabbit. Fed Proc 41: 1376 (Abstr 6463) 37. Sparks JW, Pegorier JP, Girard J, Battaglia FC 1981 Substrate concentration changes during pregnancy in the guinea pig studied under unstressed steady state conditions. Pediatr Res 15:1340 38. Strubbe JH, Gorissen J 1980 Meal patterning in the lactating rat. Physiol Behav 25:775 39. Sutter-Dub MT, Leclercq R, Felix JM, Jacquot R, Sutter BCJ 1973 Serum progesterone and immunoreactive insulin levels in the pregnant rat. Horm Metab Res 5: 18 40. Unger R, Orci L 1981 Glucogon and the A cell. Physiology and pathophysiology. N Engl J Med 304: 1518 41. Victor AL 1974 Normal blood sugar variation during pregnancy. Acta Obstet Gynecol Scand 53:37 42. Zilversmit DB, Hughes LB, Remington M 1972 Hypolipidemic effect of pregnancy in the rabbit. J Lipid Res 13:750 003 1-399818411809-0859$02.00/0 PEDIATRIC RESEARCH Copyright O 1984 International Pediatric Research Foundation, Inc. Vol. 18, No. 9, 1984 Printed in U.S.A. Vasodilators and Ventricular Septa1 Defect: Comparison of Prazosin, Minoxidil, and Hydralazine in a Chronic Lamb Model MARK M. BOUCEK, RICHARD CHANG, AND DAVID P. SYNHORST Department of Pediatrics, Division of Pediatric Cardiology, University of Utah College of Medicine and Primary Children's Medical Center, Salt Lake City, Utah 84132 Summary The volume overloading of the left ventricle which results from left to right (L-R) shunting through a ventricular septal defect (VSD) may be reduced by pharmacologic agents which lower systemic vascular resistance (R,) in excess of pulmonary arteriolar vascular resistance (R,). To study agents capable of decreasing the L-R shunt through systemic vasodilatation, we created a chronic lamb model with VSD and administered three vasodilators, prazosin (0.05 mg/kg), hydralazine (0.75 mg/kg), and minoxidil (0.25 mg/kg). Prazosin increased the R, while lowering R,, resulting in an increase in R,/R by 43% ( p Q 0.005). Prazosin decreased the pulmonary flow (Q,) slightly, decreased L-R shunt by 16%, reduced the pulmonary to systemic flow ratio Received July 25, 1983; accepted February 7, 1984. Correspondence may be addressed to Mark M. Boucek, M.D., Division of Pediatric Cardiology, Room 2B-415, University of Utah College of Medicine, Salt Lake City, UT 84132. This work was supported in part by United States Public Health Service Grants HL2 1203 and HL27802 and The Thrasher Research Fund. (QP/QS)b c 2 % ( p Q 0.005), and lowered the left atrial mean pressure (LA) by 16% ( p s 0.005) with no effect on heart rate. Hydralazine lowered the R, and R, equally and thus did not change the R,/R, or the v o l s e of L-R shunt (7.6 versus 8.1 liters/min/m2). No change in LA was seen with hydralazine but heart rate increased from 162 to 200/min (p 4 0.01). Minoxidil did not change the L-R shunt (6.9 versus 6.8 liters/min/m2) and, in general, produced effects intermediate between prazosin and hydralazine. The data support a selective systemic vasodilation with prazosin, a property not shared by either minoxidil or hydralazine, which results in a reduction of shunting and left ventricular volume overloading in lambs with VSD. Furthermore, since prazosin did not decrease the pulmonary resistance, the data indicate that the elevation in pulmonary resistance in lambs with VSD is not mediated by the a,-adrenergic receptor. Abbreviations VSD, ventricular septal defect R,, pulmonary arteriolar vascular resistance 860 BOUCEK ET AL. R, systemic vascular resistance L R , left to right QJQ, ratios, pulmonary to systemic blood flow ratios Ao, mean aortic pressure BSA, body surface area The amount of left to right shunting found in the presence of a large VSD is determined largely by the ratio of R, to R,. Pharmacologic manipulation of these vascular beds may increase the Rpa/R, ratio and reduce interventricular shunting and volume overloading of the left ventricle. The mechanisms by which pulmonary arteriolar resistance is regulated in the presence of a lef (...truncated)


This is a preview of a remote PDF: https://www.nature.com/articles/pr19842172.pdf
Article home page: https://www.nature.com/articles/pr19842172

Mark M Boucek, Richard Chang, David P Synhorst. Vasodilators and Ventricular Septal Defect: Comparison of Prazosin, Minoxidil, and Hydralazine in a Chronic Lamb Model, Pediatric Research, 1984, pp. 859-864, DOI: 10.1203/00006450-198409000-00011